Si-Bone (SIBN) Cash & Current Investments (2017 - 2026)
Si-Bone (SIBN) posted quarterly Cash & Current Investments of $144.7 million for Q1 2026, little changed year-over-year from $144.4 million in Q1 2025, and down 2.12% quarter-over-quarter from $147.8 million in Q4 2025.
Si-Bone (SIBN) Cash & Current Investments (2017 - 2026) Analysis & Trends
Si-Bone's Cash & Current Investments history runs 10 years deep, the most recent figure standing at $144.7 million for Q1 2026.
- In Q1 2026, Cash & Current Investments changed 0.19% year-over-year to $144.7 million; the TTM figure through Mar 2026 stood at $144.7 million (changed 0.19% YoY), while the FY2025 annual figure was $147.8 million, down 1.48% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $144.7 million, down from $147.8 million in the prior quarter.
- The five-year high for Cash & Current Investments was $166.8 million in Q3 2023, with the low at $78.6 million in Q1 2023.
- The 5-year median for Cash & Current Investments is $145.7 million (2025), against an average of $134.7 million.
- The sharpest annual moves came in 2022 and 2024: Cash & Current Investments sank 40.18% in 2022, then jumped 89.23% in 2024.
- Si-Bone's Cash & Current Investments stood at $84.6 million in 2022, then soared by 84.55% to $156.1 million in 2023, then slipped by 3.87% to $150.0 million in 2024, then retreated by 1.48% to $147.8 million in 2025, then declined by 2.12% to $144.7 million in 2026.
- Business Quant data shows SIBN's Cash & Current Investments at $144.7 million in Q1 2026, $147.8 million in Q4 2025, and $145.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Si-Bone | 887.32 Mn | 741.38 Mn | 44.55 Mn | 145.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 145.94 Mn |
| Mar 31, 2026 | 144.68 Mn |
| Dec 31, 2025 | 147.82 Mn |
| Sep 30, 2025 | 145.74 Mn |
| Jun 30, 2025 | 145.54 Mn |
| Mar 31, 2025 | 144.41 Mn |
| Dec 31, 2024 | 150.04 Mn |
| Sep 30, 2024 | 146.76 Mn |
| Jun 30, 2024 | 147.64 Mn |
| Mar 31, 2024 | 148.74 Mn |
| Dec 31, 2023 | 156.08 Mn |
| Sep 30, 2023 | 166.75 Mn |
| Jun 30, 2023 | 151.67 Mn |
| Mar 31, 2023 | 78.60 Mn |
| Dec 31, 2022 | 84.58 Mn |
| Sep 30, 2022 | 96.68 Mn |
| Jun 30, 2022 | 108.18 Mn |
| Mar 31, 2022 | 125.18 Mn |
| Dec 31, 2021 | 141.39 Mn |
| Sep 30, 2021 | 155.21 Mn |